Mindpath Health Psychiatrists & Therapists - Fayetteville
1990 Fordham Drive, Suite 202, Fayetteville
4.6(103 Google reviews)
United States
5 listed treatment centers serving Fayetteville and the surrounding area.
1990 Fordham Drive, Suite 202, Fayetteville
4.6(103 Google reviews)
For people in Fayetteville considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and how services are billed. Both the medication and the supervised treatment and monitoring visit may generate charges. Ask for an estimate that explains these components rather than assuming one quoted charge includes everything.
Prior authorization and documentation of earlier antidepressant trials are common requirements. Ask the treatment center what records it needs, such as medication names, treatment dates, and your response to treatment. Your previous prescriber may be able to help assemble that history. An evaluation does not guarantee that an insurer will authorize treatment.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. North Carolina Medicaid coverage also depends on the applicable plan and requirements. Coverage and a center’s willingness to accept your insurance are separate questions. The Fayetteville directory entries currently indicate that the listed centers do not accept Medicare or Medicaid; confirm directly before scheduling.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Eligibility restrictions apply, and assistance should not be assumed to cover every visit-related charge.
Before starting, ask the center and insurer:
Include transportation and time away from work in your personal budget.
SPRAVATO® treatment requires repeated trips to a REMS-certified healthcare setting. You administer the nasal spray yourself under direct observation by a healthcare provider; it is never supplied for home use. Fayetteville has five centers listed as offering treatment, but their REMS certification is not verified in these directory records. Confirm certification and current appointment availability directly.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, then weekly visits during weeks 5–8. Maintenance visits may be weekly or every two weeks. Your prescriber individualizes the schedule, so do not assume visits will become less frequent on a fixed date.
Monitoring lasts at least two hours after each dose, and the complete appointment may take longer because of preparation and assessment before leaving. When arranging time off work, allow for the full appointment and transportation rather than reserving only two hours. Discuss any driving or machinery-related job duties with your clinician.
You need someone else to drive you home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a reliable ride for every visit, identify a backup person, and ask the center about its pickup and discharge requirements before relying on a paid ride service.
If no Fayetteville listing is available when you search, or local centers cannot accommodate you, the directory also lists centers in Cary, Raleigh, Durham, Wilmington, Greensboro, Winston-Salem, Charlotte, and Huntersville. These listings do not establish certification or availability. Confirm both, and consider whether repeated trips and return rides are manageable before committing.
The directory lists five Fayetteville centers as offering Spravato, but their REMS certification is not verified in the available records. Contact a center and ask whether the specific treatment location is currently REMS-certified and accepting new patients. Also confirm its evaluation process, appointment availability, and insurance arrangements before scheduling. A directory listing alone is not proof of certification.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your diagnosis, previous treatment, and health history to determine whether it is appropriate.
Coverage depends on your plan and treatment setting. Prior authorization and records of earlier antidepressant trials are common requirements, and medication and monitoring may be billed separately. Medicare and North Carolina Medicaid may cover treatment under applicable rules, but the Fayetteville listings currently indicate no Medicare or Medicaid acceptance. Confirm directly with both the center and insurer; coverage does not guarantee that a particular center accepts your plan.
At a REMS-certified setting, you self-administer the nasal spray under direct observation by a healthcare provider. Staff monitor you for at least two hours afterward, including checks for sedation, dissociation, breathing problems, and blood pressure increases. The full visit may take longer. Someone else must take you home, and you cannot drive or operate machinery until the next day after a restful sleep.
Ask about sedation, dissociation, breathing problems, and increased blood pressure. Dissociation can involve feeling disconnected from yourself or your surroundings. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your health history and concerns with the prescriber so you understand the risks and required monitoring.
No. If you are in a suicidal crisis, call or text 988; call 911 for an immediate emergency. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, even though it has an approved use for depressive symptoms in certain adults with acute suicidal thoughts or behavior. Treatment does not replace hospitalization when a clinician determines that hospital care is needed.
Approved uses, nearby treatment centers, and medically sourced patient guides.